Skip to main content
Article
Correction to: Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial.
Articles, Abstracts, and Reports
  • J A Walsh
  • A B Gottlieb
  • B Hoepken
  • T Nurminen
  • P J Mease, Swedish Medical Center and University of Washington, Seattle, WA, USA.
Document Type
Article
Publication Date
12-1-2018
Disciplines
Abstract

The above article originally published with an error present in Discussion section and presented correctly in this article. The original article was corrected.

Clinical Institute
Orthopedics & Sports Medicine
Department
Orthopedics
Department
Rheumatology
Citation Information
J A Walsh, A B Gottlieb, B Hoepken, T Nurminen, et al.. "Correction to: Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial." (2018)
Available at: http://works.bepress.com/philip-mease/375/